Publicacions
-
Young-Silva Y, Berenguera A, Jacques-Aviñó C, Gil MM, Arroyo P, Chela-Alvarez X, Ripoll J, Martí-Lluch R, Ramos R, Elizondo-Alzola U, Garcia-Martinez S, Méndez-López F, Tamayo-Morales O, Martínez-Andrés M, Motrico E, Gómez-Gómez I, Fernández-Alvarez R and Juvinyà-Canal D.
Role of personal aptitudes as determinants of incident morbidity, lifestyles, quality of life, use of the health services and mortality (DESVELA cohort): qualitative study protocol for a prospective cohort study in a hybrid analysis
Frontiers in public health . 11: 1069957-1069957.
-
Siddi S, Bailon R, Giné I, Matcham F, Lamers F, Kontaxis S, Laporta E, Garcia E, Lombardini F, Annas P, Hotopf M, Penninx BWJH, Ivan A, White KM, Difrancesco S, Locatelli P, Aguiló J, Peñarrubia-María MT, Narayan VA, Folarin A, Leightley D, Cummins N, Vairavan S, Ranjan Y, Rintala A, de Girolamo G, Simblett SK, Wykes T, Myin-Germeys I, Dobson R and Haro JM.
The usability of daytime and night-time heart rate dynamics as digital biomarkers of depression severity
PSYCHOLOGICAL MEDICINE . 53(8): 3249-3260.
-
Serra C, Vila R, del Cacho N, Butjosa A, Manuel Abella Villena, Colomer A, Cunill R, Tena MC, Véliz DI, Bustos-Cardona T, Dolz M, Profep Group and Usall J.
Association of perceived social support with sociodemographic, clinical, and psychosocial variables in patients with first-episode psychosis.
JOURNAL OF PSYCHIATRIC RESEARCH . 162: 30-36. Nº de cites: 1
-
Parody-Rua E, Bustamante A, Montaner J, Rubio-Valera M, Serrano D, Pérez-Sánchez S, Sanchez A, Guevara-Cuellar C and Serrano-Blanco A.
Modeling the potential efficiency of a blood biomarker-based tool to guide pre-hospital thrombolytic therapy in stroke patients.
EUROPEAN JOURNAL OF HEALTH ECONOMICS . 24(4): 621-632.
-
Novais T, Fortini C, Dima AL, Schott AM, Viprey M and Schneider MP.
Se former à l’entretien motivationnel pour mieux soutenir l’adhésion thérapeutique des patients
Revue Medicale Suisse . 19(823): 777-781.
-
Sanabria JP, Doval E, Bernadàs A, Angarita-Osorio N, Colomer A, Evans-Lacko S, Thornicroft G, Luciano JV and Rubio-Valera M.
Over 40 years (1981-2023) assessing stigma with the Community Attitudes to Mental Illness (CAMI) scale: a systematic review of its psychometric properties
Systematic Reviews . 12(1): 66-66.
-
Lavalle R, Condominas E, Haro JM, Giné I, Bailon R, Laporta E, Garcia E, Kontaxis S, Alacid GR, Lombardini F, Preti A, Peñarrubia-María MT, Coromina M, Arranz B, Vilella E, Rubio E, Radar-Mdd Spain, Matcham F, Lamers F, Hotopf M, Penninx BWJH, Annas P, Narayan V, Simblett SK, Siddi S and The Radar-Cns Consortium.
The Impact of COVID-19 Lockdown on Adults with Major Depressive Disorder from Catalonia: A Decentralized Longitudinal Study.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH . 20(6): .
-
Kardas, P, Agh, T, Dima AL, Goetzinger, C, Potocnjak, I, Wettermark, B and van Boven, JFM.
Half a Century of Fragmented Research on Deviations from Advised Therapies: Is This a Good Time to Call for Multidisciplinary Medication Adherence Research Centres of Excellence?
Pharmaceutics . 15(3): . Nº de cites: 3
-
Cuñat O, Del Hoyo-Buxo B, Vila R, Serra C, Butjosa A, del Cacho N, Colomer A, Dolz M, Cuevas-Esteban J, Iglesias M, Usall J and Profep Group.
Negative symptoms in drug-naive patients with a first-episode psychosis (FEP)
Asian Journal of Psychiatry . 81: 103448-103448. Nº de cites: 1
-
Bhattacharya D, Brown TJ, Clark AB, Dima AL, Easthall C, Taylor N and Li Z.
Validation of the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q) ; a Behavioural Science-Underpinned Tool for Identifying Non-Adherence and Diagnosing an Individual's Barriers to Adherence
PATIENT PREFERENCE AND ADHERENCE . 17: 2991-3000.